Literature DB >> 7840652

Identification of 3'-methoxy-4'-nitroflavone as a pure aryl hydrocarbon (Ah) receptor antagonist and evidence for more than one form of the nuclear Ah receptor in MCF-7 human breast cancer cells.

Y F Lu1, M Santostefano, B D Cunningham, M D Threadgill, S Safe.   

Abstract

The competitive binding of 3'-methoxy-4'-nitro, 4'-amino-3'-methoxy, 4'-methoxy-3'-nitro, and 3'-amino-4'-methoxyflavone (compounds 1 to 4, respectively) to the rat cytosolic aryl hydrocarbon (Ah) receptor gave IC50 values of 2.27, 86.1, 872, and 19.4 nM. Flavones 3 and 4 were characterized as Ah receptor agonists in MCF-7 human breast cancer cells and induced CYP1A1 gene expression, whereas the 3-methoxy-substituted flavones (1 and 2) were inactive. All four compounds inhibited induction of ethoxyresorufin O-deethylase (EROD) activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells; moreover, in vitro studies with TCDD-induced rat liver microsomes showed that flavones 1 to 4 inhibited EROD activity in the presence or absence of NADPH. In MCF-7 cells cotreated with flavones 1 or 2 (0.01 to 10 microM) plus TCDD or [3H]TCDD, there was a concentration-dependent inhibition of TCDD-induced CYP1A1 mRNA levels and formation of radiolabeled nuclear Ah receptor complex. Velocity sedimentation analysis of nuclear extracts from MCF-7 cells treated with [3H]TCDD plus 1 or 10 microM concentrations of flavones 1 and 2 showed that an early eluting specifically bound nuclear Ah receptor complex was present. However, under these same conditions the flavones inhibited TCDD-induced CYP1A1 gene expression. The apparent molecular mass of this nuclear complex was 190 kDa as determined by cross-linking to a 32P-labeled bromodeoxyuridine-substituted consensus dioxin-responsive element. Similar cross-linking results were obtained using the nuclear extract from MCF-7 cells treated with [3H]TCDD alone. The results of this study suggest that there are at least two forms of the nuclear Ah receptor complex in MCF-7 cells; the major transcriptionally active form binds [3H]TCDD and flavones 1 or 2 inhibit nuclear uptake of this receptor complex. The other form of the nuclear Ah receptor complex appears to be transcriptionally inactive and ligand binding with [3H]TCDD is not competitively inhibited by flavones 1 and 2.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7840652     DOI: 10.1006/abbi.1995.1062

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  24 in total

1.  The new aryl hydrocarbon receptor antagonist E/Z-2-benzylindene-5,6-dimethoxy-3,3-dimethylindan-1-one protects against UVB-induced signal transduction.

Authors:  Julia Tigges; Thomas Haarmann-Stemmann; Christoph F A Vogel; Annemarie Grindel; Ulrike Hübenthal; Heidi Brenden; Susanne Grether-Beck; Gabriele Vielhaber; William Johncock; Jean Krutmann; Ellen Fritsche
Journal:  J Invest Dermatol       Date:  2013-08-30       Impact factor: 8.551

2.  Identification of a high-affinity ligand that exhibits complete aryl hydrocarbon receptor antagonism.

Authors:  Kayla J Smith; Iain A Murray; Rachel Tanos; John Tellew; Anthony E Boitano; William H Bisson; Siva K Kolluri; Michael P Cooke; Gary H Perdew
Journal:  J Pharmacol Exp Ther       Date:  2011-04-14       Impact factor: 4.030

3.  Aryl hydrocarbon receptor-mediated impairment of chondrogenesis and fracture healing by cigarette smoke and benzo(a)pyrene.

Authors:  Ming H Kung; Kiminori Yukata; Regis J O'Keefe; Michael J Zuscik
Journal:  J Cell Physiol       Date:  2012-03       Impact factor: 6.384

4.  Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor.

Authors:  Emma Wincent; Johanna Bengtsson; Afshin Mohammadi Bardbori; Tomas Alsberg; Sandra Luecke; Ulf Rannug; Agneta Rannug
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-05       Impact factor: 11.205

5.  Suppression of cytokine-mediated complement factor gene expression through selective activation of the Ah receptor with 3',4'-dimethoxy-α-naphthoflavone.

Authors:  Iain A Murray; Colin A Flaveny; Christopher R Chiaro; Arun K Sharma; Rachel S Tanos; Jennifer C Schroeder; Shantu G Amin; William H Bisson; Siva K Kolluri; Gary H Perdew
Journal:  Mol Pharmacol       Date:  2010-12-02       Impact factor: 4.436

6.  Development of novel CH223191-based antagonists of the aryl hydrocarbon receptor.

Authors:  Eun-Young Choi; Hyosung Lee; R W Cameron Dingle; Kyung Bo Kim; Hollie I Swanson
Journal:  Mol Pharmacol       Date:  2011-10-03       Impact factor: 4.436

7.  Ligand displaces heat shock protein 90 from overlapping binding sites within the aryl hydrocarbon receptor ligand-binding domain.

Authors:  Anatoly Soshilov; Michael S Denison
Journal:  J Biol Chem       Date:  2011-08-19       Impact factor: 5.157

8.  Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators.

Authors:  Carolyn D DuSell; Erik R Nelson; Bryan M Wittmann; Jackie A Fretz; Dmitri Kazmin; Russell S Thomas; J Wesley Pike; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2009-11-09

9.  Activation of the aryl hydrocarbon receptor by the widely used Src family kinase inhibitor 4-amino-5-(4-chlorophenyl)-7-(dimethylethyl)pyrazolo[3,4-d]pyrimidine (PP2).

Authors:  Katrin Frauenstein; Julia Tigges; Anatoly A Soshilov; Sarah Kado; Nadeshda Raab; Ellen Fritsche; Judith Haendeler; Michael S Denison; Christoph F A Vogel; Thomas Haarmann-Stemmann
Journal:  Arch Toxicol       Date:  2014-08-01       Impact factor: 5.153

Review 10.  Activation of the aryl hydrocarbon receptor by TCDD inhibits senescence: a tumor promoting event?

Authors:  S Ray; H I Swanson
Journal:  Biochem Pharmacol       Date:  2008-11-27       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.